相关实验视频

Updated: Jun 27, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

为治疗进步解码瘤血管生成:机械洞察力

Geetika Kaur^1,2, Bipradas Roy³

¹Integrative Biosciences Center, Wayne State University, Detroit, MI 48202, USA.

|April 27, 2024

概括

瘤血管生成,在瘤中产生新的血管,促进癌症的生长和扩散. 了解其分子驱动因素是开发新抗癌疗法的关键.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物医学工程生物医学工程

背景情况:

瘤血管生成是癌症的关键标志,对于瘤生长,入侵和转移至关重要.
瘤微环境涉及一种动态平衡的益血管性和抗血管性因素,控制血管形成.
向瘤血管化是癌症治疗的一个有希望的策略.

研究的目的:

为提供关于瘤血管生成的全面审查.
阐明控制瘤血管化的分子机制和调节网络.
讨论向血管生成的临床影响和治疗潜力.

主要方法:

关于瘤血管生成的现有文献的综述.
对参与新血管化的分子通路和信号网络的分析.
对诊断和预后生物标志物的检查.
临床前和临床抗血管原性疗法的评估.

主要成果:

详细描述了瘤血管生成中的关键分子参与者和信号级联.
在血管生成过程中确定关键的调节检查点.
目前和新兴的抗血管原性治疗策略的概述.
讨论该领域的挑战和未来方向.

结论:

瘤血管生成是一个复杂的,多因素的过程,对癌症的进展至关重要.
向血管生成提供了一个可行的治疗途径,但仍然存在挑战.
对分子复杂性和组合疗法的进一步研究对于改善患者的治疗结果至关重要.

关键词:

血管新生素是一种血管新生素.抗血管性因素抗血管性因素内静止素是一种内静止素.纤维细胞生长因子的成长因子它们包括interleukins和interleukins.矩阵金属蛋白酶是一种基质蛋白酶.来自血小板的生长因子.亲血管原性因素是什么瘤血管新生发生.血管内皮生长因子血管内皮生长因子

更多相关视频

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

相关概念视频

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...